{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:59:48Z","timestamp":1790182788634,"version":"4.1.0"},"reference-count":145,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2016,7,1]]},"DOI":"10.3233\/jhd-160199","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T10:52:56Z","timestamp":1467370376000},"page":"99-131","source":"Crossref","is-referenced-by-count":36,"title":["Induced Pluripotent Stem Cells in\u00a0Huntington\u2019s Disease Research: Progress\u00a0and Opportunity"],"prefix":"10.1177","volume":"5","author":[{"given":"Adelaide","family":"Tousley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly B.","family":"Kegel-Gleason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JHD-160199_ref1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.3233\/JHD-160199_ref2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem (iPS) cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.3233\/JHD-160199_ref3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.3233\/JHD-160199_ref4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2013.06.002","article-title":"Remodeling neurodegeneration: Somatic cell reprogramming-based models of adult neurological disorders","volume":"78","author":"Qiang","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JHD-160199_ref5","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2009-02-204800","article-title":"Generation of induced pluripotent stem cells from human blood","volume":"113","author":"Loh","year":"2009","journal-title":"Blood"},{"key":"10.3233\/JHD-160199_ref6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/cr.2011.12","article-title":"Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures","volume":"21","author":"Chou","year":"2011","journal-title":"Cell Res"},{"key":"10.3233\/JHD-160199_ref7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/nbt.1503","article-title":"Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes","volume":"26","author":"Aasen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JHD-160199_ref8","first-page":"768391","article-title":"A comparative view on human somatic cell sources for iPSC generation","author":"Raab","year":"2014","journal-title":"Stem Cells Int"},{"key":"10.3233\/JHD-160199_ref9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1681\/ASN.2011010106","article-title":"Generation of induced pluripotent stem cells from urine","volume":"22","author":"Zhou","year":"2011","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.3233\/JHD-160199_ref10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nbt.3070","article-title":"A comparison of non-integrating reprogramming methods","volume":"33","author":"Schlaeger","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JHD-160199_ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrg2937","article-title":"Methods for making induced pluripotent stem cells: Reprogramming \u00e1 la carte","volume":"12","author":"Gonz\u00e1lez","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.3233\/JHD-160199_ref12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1089\/scd.2013.0620","article-title":"All roads lead to induced pluripotent stem cells: The technologies of iPSC generation","volume":"23","author":"Hu","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.3233\/JHD-160199_ref13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12015-015-9622-8","article-title":"Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies","volume":"12","author":"Brouwer","year":"2015","journal-title":"Stem Cell Rev Re"},{"key":"10.3233\/JHD-160199_ref14","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1172\/JCI70911","article-title":"Inhibition of mitochondrial fragmentation diminishes Huntington\u2019s disease-associated neurodegeneration","volume":"123","author":"Guo","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JHD-160199_ref15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"The HD iPSC Consortium","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","article-title":"The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity","volume":"46","author":"Camnasio","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-160199_ref17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","article-title":"Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient","volume":"446","author":"Chae","year":"2012","journal-title":"Biochem J"},{"key":"10.3233\/JHD-160199_ref19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","article-title":"Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington\u2019s disease neural stem cells","volume":"5","author":"Ring","year":"2015","journal-title":"Stem Cell Re"},{"key":"10.3233\/JHD-160199_ref20","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/stem.1430","article-title":"High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes","volume":"31","author":"Charbord","year":"2013","journal-title":"Stem Cells Dayt Ohio"},{"key":"10.3233\/JHD-160199_ref21","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s12035-014-8974-4","article-title":"Inhibition of excessive monoamine oxidase A\/B activity protects against stress-induced neuronal death in Huntington disease","volume":"52","author":"Ooi","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JHD-160199_ref22","first-page":"1","article-title":"RTP801 is involved in mutant huntingtin-induced cell death","author":"Mart\u00edn-Flores","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JHD-160199_ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15283\/ijsc.2014.7.1.43","article-title":"In vivo roles of a patient-derived induced pluripotent stem cell line (HD72-iPSC) in the YAC128 model of Huntington\u2019s disease","volume":"7","author":"Jeon","year":"2014","journal-title":"Int J Stem Cells"},{"key":"10.3233\/JHD-160199_ref24","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/stem.1135","article-title":"Neuronal Properties, in vivo effects, and pathology of a Huntington\u2019s disease patient-derived induced pluripotent stem cells","volume":"30","author":"Jeon","year":"2012","journal-title":"Stem Cells"},{"key":"10.3233\/JHD-160199_ref25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2013.05.025","article-title":"miR-196a ameliorates phenotypes of Huntington disease in cell, transgenic mouse, and induced pluripotent stem cell models","volume":"93","author":"Cheng","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JHD-160199_ref26","first-page":"ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease","author":"Hsiao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref27","first-page":"4","article-title":"A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity","author":"Yao","year":"2015","journal-title":"eLife"},{"key":"10.3233\/JHD-160199_ref28","doi-asserted-by":"crossref","first-page":"RRN1193","DOI":"10.1371\/currents.RRN1193","article-title":"Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells","volume":"2","author":"Zhang","year":"2010","journal-title":"PLoS Curr"},{"key":"10.3233\/JHD-160199_ref29","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1073\/pnas.1103509108","article-title":"Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors","volume":"108","author":"Ban","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-160199_ref30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.1162494","article-title":"Induced pluripotent stem cells generated without viral integration","volume":"322","author":"Stadtfeld","year":"2008","journal-title":"Science"},{"key":"10.3233\/JHD-160199_ref31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"key":"10.3233\/JHD-160199_ref32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.05.005","article-title":"Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins","volume":"4","author":"Kim","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1126\/science.1239278","article-title":"Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds","volume":"341","author":"Hou","year":"2013","journal-title":"Science"},{"key":"10.3233\/JHD-160199_ref35","doi-asserted-by":"crossref","first-page":"e17557","DOI":"10.1371\/journal.pone.0017557","article-title":"Efficient feeder-free episomal reprogramming with small molecules","volume":"6","author":"Yu","year":"2011","journal-title":"PloS One"},{"key":"10.3233\/JHD-160199_ref36","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref37","first-page":"ddu609","article-title":"A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington\u2019s disease","author":"Tidball","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref38","doi-asserted-by":"crossref","first-page":"268ra178","DOI":"10.1126\/scitranslmed.3010523","article-title":"Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease","volume":"6","author":"Lu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3233\/JHD-160199_ref39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.4003","article-title":"PPAR-\u03b4 is repressed in Huntington\u2019s disease, is required for normal neuronal function and can be targeted therapeutically","volume":"22","author":"Dickey","year":"2016","journal-title":"Nat Med"},{"key":"10.3233\/JHD-160199_ref40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-6606-5-17","article-title":"Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington\u2019s disease patient cells","volume":"5","author":"Juopperi","year":"2012","journal-title":"Mol Brain"},{"key":"10.3233\/JHD-160199_ref41","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1242\/dmm.019406","article-title":"Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway","volume":"8","author":"Szlachcic","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.3233\/JHD-160199_ref42","doi-asserted-by":"crossref","first-page":"e0150372","DOI":"10.1371\/journal.pone.0150372","article-title":"Genomic instability associated with p53 knockdown in the generation of Huntington\u2019s disease human induced pluripotent stem cells","volume":"11","author":"Tidball","year":"2016","journal-title":"PloS One"},{"key":"10.3233\/JHD-160199_ref43","doi-asserted-by":"crossref","first-page":"6066","DOI":"10.1093\/hmg\/ddv318","article-title":"Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington\u2019s disease iPSCs","volume":"24","author":"Chiu","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref44","first-page":"6","article-title":"Polyglutamine disease modeling: Epitope based screen for homologous recombination using CRISPR\/Cas9 system","author":"An","year":"2014","journal-title":"PLoS Curr"},{"key":"10.3233\/JHD-160199_ref45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/rme.15.25","article-title":"Developing stem cell therapies for juvenile and adult-onset Huntington\u2019s disease","volume":"10","author":"Fink","year":"2015","journal-title":"Regen Med"},{"key":"10.3233\/JHD-160199_ref46","doi-asserted-by":"crossref","first-page":"e002085","DOI":"10.1136\/bmjopen-2012-002085","article-title":"Juvenile Huntington\u2019s disease: A population-based study using the General Practice Research Database","volume":"3","author":"Douglas","year":"2013","journal-title":"BMJ Open"},{"key":"10.3233\/JHD-160199_ref47","first-page":"4","article-title":"The prevalence of juvenile Huntington\u2019s disease: A review of the literature and meta-analysis","author":"Quarrell","year":"2012","journal-title":"PLoS Curr"},{"key":"10.3233\/JHD-160199_ref48","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","article-title":"Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS","volume":"80","author":"Killoran","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JHD-160199_ref49","first-page":"7","article-title":"Characterization of forebrain neurons derived from late-onset Huntington\u2019s disease human embryonic stem cell lines","author":"Niclis","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JHD-160199_ref50","doi-asserted-by":"crossref","unstructured":"Zhang N , Bailus BJ , Ring KL , Ellerby LM . iPSC-based drug screening for Huntington\u2019s disease. Brain Res. 2015. doi: 10.1016\/j.brainres.2015.09.020","DOI":"10.1016\/j.brainres.2015.09.020"},{"key":"10.3233\/JHD-160199_ref51","doi-asserted-by":"crossref","unstructured":"Mattis VB , Svendsen CN . Modeling Huntington\u2019s disease with patient-derived neurons. Brain Res 2015. doi: 10.1016\/j.brainres.2015.10.001","DOI":"10.1016\/j.brainres.2015.10.001"},{"key":"10.3233\/JHD-160199_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-014-8694-9","article-title":"Induced pluripotent stem cells in Huntington\u2019s disease: Disease modeling and the potential for cell-based therapy","author":"Liu","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JHD-160199_ref53","doi-asserted-by":"crossref","unstructured":"Golas MM , Sander B . Use of human stem cells in Huntington disease modeling and translational research. Exp Neurol. 2016. doi: 10.1016\/j.expneurol.2016.01.021","DOI":"10.1016\/j.expneurol.2016.01.021"},{"key":"10.3233\/JHD-160199_ref54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mcn.2013.02.005","article-title":"Modeling Huntington\u2019s disease with induced pluripotent stem cells","volume":"56","author":"Kaye","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JHD-160199_ref55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.stem.2015.12.002","article-title":"Genome editing in human pluripotent stem cells: Approaches, pitfalls, and solutions","volume":"18","author":"Hendriks","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref56","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.3233\/JHD-160199_ref57","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/stem.1462","article-title":"Embryonic stem cells neural differentiation qualifies the role of Wnt\/\u03b2-Catenin signals in human telencephalic specification and regionalization","volume":"31","author":"Nicoleau","year":"2013","journal-title":"Stem Cells"},{"key":"10.3233\/JHD-160199_ref58","first-page":"4055","article-title":"Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells","volume":"136","author":"Li","year":"2009","journal-title":"Dev Camb Engl"},{"key":"10.3233\/JHD-160199_ref59","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1089\/scd.2010.0282","article-title":"Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway","volume":"20","author":"El-Akabawy","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.3233\/JHD-160199_ref60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.neuron.2014.10.016","article-title":"Generation of human striatal neurons by MicroRNA-dependent direct conversion of fibroblasts","volume":"84","author":"Victor","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JHD-160199_ref62","first-page":"1375","article-title":"Activin A directs striatal projection neuron differentiation of human pluripotent stem cells","volume":"142","author":"Arber","year":"2015","journal-title":"Dev Camb Engl"},{"key":"10.3233\/JHD-160199_ref63","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.3233\/JHD-160199_ref64","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"10.3233\/JHD-160199_ref65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuron.2009.07.015","article-title":"Distinct temporal requirements for the homeobox gene Gsx2 in specifying striatal and olfactory bulb neuronal fates","volume":"63","author":"Waclaw","year":"2009","journal-title":"Neuron"},{"key":"10.3233\/JHD-160199_ref66","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00532-0","article-title":"Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence","volume":"84","author":"Olsson","year":"1998","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-160199_ref67","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/nn.3860","article-title":"Molecular and functional definition of the developing human striatum","volume":"17","author":"Onorati","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.3233\/JHD-160199_ref68","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jnr.10638","article-title":"Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum","volume":"73","author":"Takahashi","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.3233\/JHD-160199_ref69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neuroscience.2003.11.036","article-title":"Foxp1 gene expression in projection neurons of the mouse striatum","volume":"124","author":"Tamura","year":"2004","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-160199_ref70","doi-asserted-by":"crossref","first-page":"e1100227","DOI":"10.1080\/23262133.2015.1100227","article-title":"How to make striatal projection neurons","volume":"2","author":"Fjodorova","year":"2015","journal-title":"Neurogenesis"},{"key":"10.3233\/JHD-160199_ref71","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5966\/sctm.2014-0083","article-title":"In vitro differentiation of human neural progenitor cells into striatal GABAergic neurons","volume":"4","author":"Lin","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.3233\/JHD-160199_ref72","first-page":"301","article-title":"Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-32+medium-sized spiny neurons","volume":"140","author":"Delli","year":"2013","journal-title":"Dev Camb Engl"},{"key":"10.3233\/JHD-160199_ref73","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature10323","article-title":"MicroRNA-mediated conversion of human fibroblasts to neurons","volume":"476","author":"Yoo AS","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JHD-160199_ref74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","article-title":"Programming and reprogramming cellular age in the era of induced pluripotency","volume":"16","author":"Studer","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref76","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref77","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrneurol.2015.79","article-title":"Toward stem cell-based phenotypic screens for neurodegenerative diseases","volume":"11","author":"Khurana","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JHD-160199_ref78","doi-asserted-by":"crossref","first-page":"e64368","DOI":"10.1371\/journal.pone.0064368","article-title":"Selective roles of normal and mutant huntingtin in neural induction and early neurogenesis","volume":"8","author":"Nguyen","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JHD-160199_ref79","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1523\/JNEUROSCI.0715-14.2014","article-title":"Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex","volume":"34","author":"Molina-Calavita","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160199_ref80","doi-asserted-by":"crossref","first-page":"e0148680","DOI":"10.1371\/journal.pone.0148680","article-title":"Dominant-negative effects of adult-onset huntingtin mutations alter the division of human embryonic stem cells-derived neural cells","volume":"11","author":"Lopes","year":"2016","journal-title":"PloS One"},{"key":"10.3233\/JHD-160199_ref81","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.2007.06081266","article-title":"Morphology of the cerebral cortex in preclinical Huntington\u2019s disease","volume":"164","author":"Nopoulos","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JHD-160199_ref82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"Paulsen","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.3233\/JHD-160199_ref83","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","article-title":"Change in MRI striatal volumes as a biomarker in preclinical Huntington\u2019s disease","volume":"72","author":"Aylward","year":"2007","journal-title":"Brain Res Bull"},{"key":"10.3233\/JHD-160199_ref84","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000338635","article-title":"Brain structure in preclinical Huntington\u2019s disease: A multi-method approach","volume":"12","author":"Wolf","year":"2013","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JHD-160199_ref85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neulet.2012.02.095","article-title":"Impaired cortico-striatal functional connectivity in prodromal Huntington\u2019s disease","volume":"514","author":"Unschuld","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JHD-160199_ref86","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/brain\/awv145","article-title":"Network topology and functional connectivity disturbances precede the onset of Huntington\u2019s disease","volume":"138","author":"Harrington","year":"2015","journal-title":"Brain J Neurol"},{"key":"10.3233\/JHD-160199_ref87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2015.09.030","article-title":"Cortical inhibitory deficits in premanifest and early Huntington\u2019s disease","volume":"296","author":"Philpott","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.3233\/JHD-160199_ref88","first-page":"9","article-title":"Huntington\u2019s disease as neurodevelopmental disorder: Altered chromatin regulation, coding, and non-coding RNA Transcription","author":"Kerschbamer","year":"2016","journal-title":"Front Neurosci"},{"key":"10.3233\/JHD-160199_ref89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","article-title":"Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease","volume":"49","author":"G\u00f3mez-Tortosa","year":"2001","journal-title":"Ann Neurol"},{"key":"10.3233\/JHD-160199_ref90","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pscychresns.2012.01.002","article-title":"Depressive symptoms in prodromal Huntington\u2019s disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex","volume":"203","author":"Unschuld","year":"2012","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.3233\/JHD-160199_ref91","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","article-title":"A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease","volume":"24","author":"Puigdell\u00edvol","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JHD-160199_ref93","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1523\/JNEUROSCI.4699-13.2014","article-title":"Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits","volume":"34","author":"McKinstry","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160199_ref94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington\u2019s disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.3233\/JHD-160199_ref95","doi-asserted-by":"crossref","first-page":"320ec1","DOI":"10.1126\/scitranslmed.aad9760","article-title":"Is Huntington\u2019s disease a neurodevelopmental disorder?","volume":"8","author":"Brennand","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.3233\/JHD-160199_ref96","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/embor.2010.182","article-title":"Is Huntington disease a developmental disorder?","volume":"11","author":"Humbert","year":"2010","journal-title":"EMBO Rep"},{"key":"10.3233\/JHD-160199_ref97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JHD-160199_ref98","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease A clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JHD-160199_ref99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/exnr.1998.6778","article-title":"Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington\u2019s, Alzheimer\u2019s, and Pick\u2019s diseases","volume":"150","author":"Singhrao","year":"1998","journal-title":"Exp Neurol"},{"key":"10.3233\/JHD-160199_ref100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00005072-199111000-00005","article-title":"Decreased neuronal and increased oligodendroglial densities in Huntington\u2019s disease caudate nucleus","volume":"50","author":"Myers","year":"1991","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.3233\/JHD-160199_ref101","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: A correlation with Huntington\u2019s disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref102","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JHD-160199_ref103","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-160199_ref104","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J Cell Biol"},{"key":"10.3233\/JHD-160199_ref105","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington\u2019s disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JHD-160199_ref106","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington\u2019s disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.3233\/JHD-160199_ref107","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2014.110","article-title":"Impaired brain energy metabolism in the BACHD mouse model of Huntington\u2019s disease: Critical role of astrocyte-neuron interactions","volume":"34","author":"Boussicault","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JHD-160199_ref108","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.24428","article-title":"Aberrant astrocytes impair vascular reactivity in Huntington disease","volume":"78","author":"Hsiao","year":"2015","journal-title":"Ann Neurol"},{"key":"10.3233\/JHD-160199_ref109","first-page":"2016","article-title":"Neurosphere based differentiation of human iPSC improves astrocyte differentiation","author":"Zhou","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.3233\/JHD-160199_ref110","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nbt.1877","article-title":"Specification of transplantable astroglial subtypes from human pluripotent stem cells","volume":"29","author":"Krencik","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JHD-160199_ref111","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/scd.2010.0560","article-title":"Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes","volume":"21","author":"Emdad","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.3233\/JHD-160199_ref112","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.celrep.2013.06.021","article-title":"Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes","volume":"4","author":"Roybon","year":"2013","journal-title":"Cell Re"},{"key":"10.3233\/JHD-160199_ref113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/glia.22903","article-title":"Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology","volume":"64","author":"Zhang","year":"2016","journal-title":"Glia"},{"key":"10.3233\/JHD-160199_ref114","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/stem.1334","article-title":"Efficient generation of astrocytes from human pluripotent stem cells in defined conditions","volume":"31","author":"Shaltouki","year":"2013","journal-title":"Stem Cells Dayt Ohio"},{"key":"10.3233\/JHD-160199_ref115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","article-title":"Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination","volume":"12","author":"Wang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref116","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/nprot.2009.186","article-title":"Differentiation of human oligodendrocytes from pluripotent stem cells","volume":"4","author":"Hu","year":"2009","journal-title":"Nat Protoc"},{"key":"10.3233\/JHD-160199_ref117","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.mcn.2006.11.008","article-title":"Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo","volume":"34","author":"Izrael","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JHD-160199_ref118","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/glia.21159","article-title":"Differentiation of induced pluripotent stem cells into functional oligodendrocytes","volume":"59","author":"Czepiel","year":"2011","journal-title":"Glia"},{"key":"10.3233\/JHD-160199_ref119","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2008.12.010","article-title":"Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells","volume":"4","author":"Marion","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref120","doi-asserted-by":"crossref","first-page":"e8124","DOI":"10.1371\/journal.pone.0008124","article-title":"Telomere dynamics in human cells reprogrammed to pluripotency","volume":"4","author":"Suhr","year":"2009","journal-title":"PloS One"},{"key":"10.3233\/JHD-160199_ref121","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1101\/gad.173922.111","article-title":"Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state","volume":"25","author":"Lapasset","year":"2011","journal-title":"Genes Dev"},{"key":"10.3233\/JHD-160199_ref122","doi-asserted-by":"crossref","first-page":"e27352","DOI":"10.1371\/journal.pone.0027352","article-title":"Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations","volume":"6","author":"Prigione","year":"2011","journal-title":"PloS One"},{"key":"10.3233\/JHD-160199_ref123","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2016.01.012","article-title":"Stem and progenitor cell-based therapy of the central nervous system: Hopes, hype, and wishful thinking","volume":"18","author":"Goldman","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.3233\/JHD-160199_ref125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/01677063.2014.881358","article-title":"Stem cells on the brain: Modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells","volume":"28","author":"Srikanth","year":"2014","journal-title":"J Neurogenet"},{"key":"10.3233\/JHD-160199_ref126","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","article-title":"Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells","volume":"28","author":"Polo","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.3233\/JHD-160199_ref127","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature07056","article-title":"Dissecting direct reprogramming through integrative genomic analysis","volume":"454","author":"Mikkelsen","year":"2008","journal-title":"Nature"},{"key":"10.3233\/JHD-160199_ref128","doi-asserted-by":"crossref","first-page":"e0131128","DOI":"10.1371\/journal.pone.0131128","article-title":"Effects of integrating and non-integrating reprogramming methods on copy number variation and genomic stability of human induced pluripotent stem cells","volume":"10","author":"Kang","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JHD-160199_ref129","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.stem.2010.12.003","article-title":"Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture","volume":"8","author":"Laurent","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","article-title":"Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells","volume":"471","author":"Lister","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JHD-160199_ref131","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1038\/ncomms9036","article-title":"Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells","volume":"6","author":"Ruiz","year":"2015","journal-title":"Nat Commun"},{"key":"10.3233\/JHD-160199_ref132","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature09871","article-title":"Copy number variation and selection during reprogramming to pluripotency","volume":"471","author":"Hussein","year":"2011","journal-title":"Nature"},{"key":"10.3233\/JHD-160199_ref133","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mcn.2012.03.011","article-title":"Multiple phenotypes in Huntington disease mouse neural stem cells","volume":"50","author":"Ritch","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JHD-160199_ref134","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.stem.2015.06.013","article-title":"From dish to bedside: Lessons learned while translating findings from a stem cell model of disease to a clinical trial","volume":"17","author":"McNeish","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-013-1222-6","article-title":"Human stem cell models of neurodegeneration: A novel approach to study mechanisms of disease development","volume":"127","author":"Hargus","year":"2014","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JHD-160199_ref136","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jnc.12625","article-title":"Modeling human neurological disorders with induced pluripotent stem cells","volume":"129","author":"Imaizumi","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JHD-160199_ref137","doi-asserted-by":"crossref","first-page":"e1831","DOI":"10.1038\/cddis.2015.167","article-title":"Genome-editing tools for stem cell biology","volume":"6","author":"Vasileva","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.3233\/JHD-160199_ref138","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1074\/jbc.R113.488247","article-title":"A cut above the rest: Targeted genome editing technologies in human pluripotent stem cells","volume":"289","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JHD-160199_ref139","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.stem.2014.04.020","article-title":"Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing","volume":"15","author":"Veres","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref140","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s12035-013-8409-7","article-title":"DNA repair mechanisms in Huntington\u2019s disease","volume":"47","author":"Jonson","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JHD-160199_ref141","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1242\/dmm.012054","article-title":"Genome editing of human pluripotent stem cells to generate human cellular disease models","volume":"6","author":"Musunuru","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.3233\/JHD-160199_ref142","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","article-title":"Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression","volume":"12","author":"Reinhardt","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.3233\/JHD-160199_ref143","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/scd.2010.0120","article-title":"Derivation of Huntington\u2019s disease-affected human embryonic stem cell lines","volume":"20","author":"Bradley","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.3233\/JHD-160199_ref144","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1093\/hmg\/dds216","article-title":"Early transcriptional changes linked to naturally occurring Huntington\u2019s disease mutations in neural derivatives of human embryonic stem cells","volume":"21","author":"Feyeux","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JHD-160199_ref145","first-page":"10","article-title":"Three Huntington\u2019s disease specific mutation-carrying human embryonic stem cell lines have stable number of CAG repeats upon in vitro differentiation into cardiomyocytes","author":"Jacquet","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-160199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:57:10Z","timestamp":1777453030000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-160199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":145,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-160199","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,1]]}}}